Javier Nuevo

Mr. Javier Nuevo


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2020 in Advances in Therapy
Verified
Journal Article
Open access
PDF file
CJChrister Janson
Christer Janson
AMAndrew Menzies-Gow
Andrew Menzies-Gow
CNCassandra Nan
Cassandra Nan
JNJavier Nuevo
Javier Nuevo
APAlberto Papi
Alberto Papi
CVClaus F. Vogelmeier
Claus F. Vogelmeier
Introduction Globally, individuals with asthma tend to overrely on short-acting β2-agonists (SABAs) and underuse inhaled corticosteroids, thereby undertreating the underlying inflammation. Such relief-seeking behavior has been reinforced by long-standing treatment guidelines, which until recently recommended SABA-only use for immediate symptom relief. We aimed to describe the current burden of SABA use among European individuals with asthma within the SABA use IN Asthma (SABINA) program. Methods Prescription and/or dispensing data during 2006–2017 from electronic medical records and/or national patient registries in the United Kingdom (UK), Germany, Italy, Spain, and Sweden were analyzed. Individuals aged at least 12 years old with a current asthma diagnosis and no other chronic respiratory conditions were included. Asthma treatment step and severity were based on treatment guidelines in use in each individual country. The proportion of individuals prescribed SABA was measured during a 12-month period. SABA overuse was defined as at least three SABA canisters per year. Results More than one million individuals with asthma were included across five European countries. Overall, the majority of individuals were over 45 years of age, except in Sweden (mean age 27.6 years) where individuals aged over 45 years were excluded to avoid a potential chronic obstructive pulmonary disease co-diagnosis. The study population was predominantly female (55–64%), except in the UK (46%). The prevalence of SABA overuse was 9% in Italy, 16% in Germany, 29% in Spain, 30% in Sweden, and 38% in the UK. In the UK, SABA overuse was greater in individuals with moderate-to-severe asthma versus individuals with mild asthma (58% versus 27%, respectively), while SABA overuse was similar in individuals with both mild (9–32%) and moderate-to-severe (8–31%) asthma in the other European countries. Conclusions The findings of this study from the SABINA program show that SABA overuse (at least three canisters per year) is common across Europe, despite the different healthcare and reimbursement policies of each country.

2 October 2012 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
Francisco-Javier Gonzalez-BarcalaFrancisco-Javier Gonzalez-Barcala
Francisco-Javier Gonzalez-Barcala
RFRamon de la Fuente-Cid
Ramon de la Fuente-Cid
MTMónica Tafalla
Mónica Tafalla
JNJavier Nuevo
Javier Nuevo
Francisco Caamano IsornaFrancisco Caamano Isorna
Francisco Caamano Isorna
The measurement of health-related quality of life (HRQoL) is increasingly recognized as an important endpoint, as a reflection of the effects of the disease from a patient perspective. Our aim was to evaluate the factors determining the HRQoL in patients with asthma, according to the EQ-5D questionnaire.

16 October 2009 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
JGJavier P Gisbert
Javier P Gisbert
ACAlun Cooper
Alun Cooper
DKDimitrios Karagiannis
Dimitrios Karagiannis
JHJan Hatlebakk
Jan Hatlebakk
LALars Agréus
Lars Agréus
JNJavier Nuevo
Javier Nuevo
The RANGE (Retrospective ANalysis of GastroEsophageal reflux disease [GERD]) study assessed differences among patients consulting a primary care physician due to GERD-related reasons in terms of: symptoms, diagnosis and management, response to treatment, and effects on productivity, costs and health-related quality of life. This subanalysis of RANGE determined the impact of GERD on productivity in work and daily life.

1 April 2009 in Gastroenterología y Hepatología
Verified
Journal Article
Closed access
JNJavier Nuevo
Javier Nuevo
MTMónica Tafalla
Mónica Tafalla
JZJavier Zapardiel
Javier Zapardiel

31 July 2010 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
FBFrancisco Javier González Barcala
Francisco Javier González Barcala
RFRamón de la Fuente-Cid
Ramón de la Fuente-Cid
RÁRosa Álvarez-Gil
Rosa Álvarez-Gil
MTMónica Tafalla
Mónica Tafalla
JNJavier Nuevo
Javier Nuevo
Francisco Caamano IsornaFrancisco Caamano Isorna
Francisco Caamano Isorna

1 March 2011 in Gaceta Sanitaria
Verified
Journal Article
Open access
JNJavier Nuevo
Javier Nuevo
MTMónica Tafalla
Mónica Tafalla
LCLuis Cordero
Luis Cordero
MRMontserrat Ruiz
Montserrat Ruiz
ECEva Calvo
Eva Calvo
JMJesús Mayo
Jesús Mayo
ResumenLos estudios observacionales están sujetos a sesgos que pueden conducir a una interpretación errónea de los resultados. El presente estudio tuvo como objetivo determinar la influencia del tratamiento con omeprazol sobre la duración de la baja laboral en pacientes con esguince de tobillo que tomaban antiinflamatorios no esteroideos. Se utilizaron los registros de la base de datos de la mutua Ibermutuamur. En contra de lo esperado, se observó que los pacientes que recibieron omeprazol presentaron una baja más prolongada que los que no recibieron omeprazol. Es probable que estos hallazgos se deban a la influencia de un sesgo de confusión por gravedad, pues los pacientes que recibieron omeprazol presentaban un esguince más grave, aunque no se puede descartar un sesgo de confusión por indicación. Para evitar la influencia de estos errores sistemáticos se deben controlar los sesgos a lo largo de todo el estudio, desde el diseño hasta el análisis de los datos.AbstractObservational studies are subject to biases that may lead to misinterpretation of the results. This study aimed to determine the influence of omeprazole treatment on the duration of sick leave in patients with ankle sprains treated with non-steroidal anti-inflammatory drugs. We used the Ibermutuamur database. Contrary to our expectations, sick leave was longer in patients who received omeprazole than in those who did not. These findings were probably due to the influence of a bias due to confounding by severity, given that patients who received omeprazole had a worse kind of ankle sprain; however, a bias due to confounding by indication cannot be excluded. To avoid the influence of these systematic errors, biases should be monitored from the design stage to the data analysis stage